Socar Research SA   Report issue

For profit Phase 2 Phase 3
Founded: Nyon Switzerland (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2008
NCT00821717
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Socar Research SA

Active Ingredients

Drugs in Phase 3 Trials (2)

ferric carboxymaltose (Injectafer) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (1)

crizanlizumab (Adakveo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Heart Failure (Phase 3)

Vascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3